“Unlocking Dabrafenib’s Potential: A Quality by Design (QBD) Journey to Enhance Permeation and Oral Bioavailability through Nanosponge Formulation”, Braz. J. Pharm. Sci., vol. 61, Feb. 2025, doi: 10.1590/.